Company
An Oman biotechnology company with international execution reach.
Maak leads proprietary peptide research, professional development programmes and scientific partnerships from Muscat.
Company purpose
Build valuable biotechnology programmes from Oman.
Maak originates and manages proprietary research, including the lead MK-1 programme, and coordinates professional peptide projects for external organisations. The company retains scientific direction, quality oversight, data, intellectual property and commercial responsibility while using qualified international infrastructure for specialised execution.
Operating model
Oman-led. Internationally executed.
From Muscat, Maak defines programmes, selects partners, approves work packages, reviews technical results, manages records and advances commercial relationships. Specialist synthesis, advanced analytical testing and project-specific studies are commissioned from providers selected for the required expertise and standards.
This model places the highest-value decisions and resulting intellectual property within Maak while maintaining access to established global capability.
Corporate profile
Registered in Muscat.
Built for biotechnology.
Maak operates as an active Omani limited liability company registered for research and experimental development in natural sciences and engineering.
Proprietary programmes
Focused peptide assets supported by controlled research, data generation and intellectual-property development.
Partner programmes
Professional peptide projects that create near-term commercial activity and deepen Maak's execution network.
Oman infrastructure
A phased Muscat facility designed to anchor headquarters, quality, material operations and future technical growth.
Work with Maak